Cevimeline Hydrochloride and Promacta

• Generic Name: cevimeline
• Dosage Forms: n.a.
• Other Brand Names: Evoxac

Symptomatic treatment of dry mouth (xerostomia) in patients with Sjögren syndrome.

There are few comparative studies of cevimeline and pilocarpine (a similar muscarinic agonist). Although both drugs can increase salivary flow and improve symptoms of dry mouth, adverse effects may differ based on differences in selectivity and affinity for muscarinic receptors. (See Actions.)

• Generic Name: eltrombopag
• Dosage Forms: tablet, film coated
• Other Brand Names: Promacta

Promacta (eltrombopag) is a man-made form of a protein that increases production of platelets (blood-clotting cells) in your body. Eltrombopag can lower the risk of bleeding by increasing platelets in your blood.

Promacta is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura (ITP), a bleeding condition caused by a lack of platelets in the blood. This medicine is for use in adults and children who are at least 1 year old, after other medicines have been tried without success.

Promacta is also used to prevent bleeding in adults with chronic hepatitis C who are treated with an interferon (such as Intron A, Infergen, Pegasys, PegIntron, Rebetron, Redipen, or Sylatron).

Promacta is also used together with other medications to treat severe aplastic anemia in adults and children who are at least 2 years old.

Promacta is not a cure for ITP and it will not make your platelet counts normal if you have this condition.